Zhejiang Xinguang Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300519.SZ

Zhejiang Xinguang Pharmaceutical Co., Ltd. Market Capitalization on January 14, 2025: USD 280.14 M

Zhejiang Xinguang Pharmaceutical Co., Ltd. Market Capitalization is USD 280.14 M on January 14, 2025, a -21.80% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Zhejiang Xinguang Pharmaceutical Co., Ltd. 52-week high Market Capitalization is USD 385.63 M on October 08, 2024, which is 37.66% above the current Market Capitalization.
  • Zhejiang Xinguang Pharmaceutical Co., Ltd. 52-week low Market Capitalization is USD 216.33 M on February 07, 2024, which is -22.78% below the current Market Capitalization.
  • Zhejiang Xinguang Pharmaceutical Co., Ltd. average Market Capitalization for the last 52 weeks is USD 281.77 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
Shenzhen Stock Exchange: 300519.SZ

Zhejiang Xinguang Pharmaceutical Co., Ltd.

CEO Mr. Yue Jun Wang
IPO Date June 24, 2016
Location China
Headquarters No. 25, Huancheng West Road
Employees 315
Sector Health Care
Industries
Description

Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health foods. The company offers pharmaceutical products in the areas of cardiovascular and cerebrovascular diseases, and traumatic diseases, covering the aspects of respiratory system, digestive system, urinary system, pediatric diseases, and improving immunity. It also can produce 6 dosage forms with 49 approval numbers for drug production and 2 approval numbers for health food. It offers its products in the form of tablets, granules, syrups, powders, hard capsules, and oral solutions, as well as mixtures, including oral liquids. Zhejiang Xinguang Pharmaceutical Co., Ltd. was founded in 1970 and is headquartered in Shengzhou, China.

StockViz Staff

January 15, 2025

Any question? Send us an email